Revolutionizing cancer diagnostics
 with one simple blood test

How it works
  • One simple blood test
  • Final diagnosis within hours
  • Outstanding reliability

A game-changing diagnostic method

With a single blood test we can determine, with certainty, if you have significant prostate cancer. It is very easy to apply to laboratory automation systems and it’s unlike anything else on the market. The current tests on the market can only show the potential risk of cancer and require further testing or biopsy to determine a clear result. The ProsMedic test requires no further testing or biopsy. You have a definitive answer within hours.

How it works

Detection and diagnosis with one test

Our mission is to reduce prostate cancer mortality with a test truly suitable for screening and early detection.

About us

The statistics that drive our scientists

Prostate cancer kills more men in Sweden than any other cancer

Traditional diagnostic methods cause unnecessary suffering

Waiting for a cancer diagnosis, regardless of outcome, is very stressful. Traditional methods include multiple steps that are both invasive, sometimes painful and require a lot of waiting. ProsMedic’s method is a single-step process that only takes a few hours. If there is significant cancer in the prostate, the test result will tell immediately.

A Swedish discovery – Our scientists have devoted over 40 years to research this field

The key to the solution was discovered by a Swedish doctor. He detected small vesicles in prostate fluid and named them prostasomes. They act as messengers in the body and carry traces of their parent cell. When a tumor develops in the prostate, prostasomes leak into the blood. Our researchers have developed antibodies that specifically bind to prostasomes. Cancer can therefore be detected or ruled out through one blood test.

Learn more

Huge amounts to be saved

The annual societal cost of prostate cancer worldwide is over 25 billion US dollars. By using ProsMedic's test, the costs will be significantly reduced.